CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Abbr. CURR PHARM BIOTECHNO ·UNITED STATES ·Frequency Bimonthly ·Avg. articles/yr 121 articles

2.6

Latest IF

3.40%

Self-citation

容易

Submission difficulty

一般,3 - 6周

Review cycle

About Journal

CURRENT PHARMACEUTICAL BIOTECHNOLOGY是一本专注于药物生物技术领域的国际期刊，ISSN号为1389-2010，由Bentham Science Publishers出版，每月发行一期，出版地位于阿拉伯联合酋长国。该期刊的影响因子根据年份有所不同，近年保持在2至3之间，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学或生物工程领域的3区或4区。该期刊的发文特点集中于药物开发、生物技术应用、基因治疗、纳米医药以及生物制药等前沿领域，尤其关注技术创新与临床转化的结合。杂志的质量较为稳定，但作为商业出版社旗下期刊，需注意其审稿速度和出版费用可能较高，且部分年份的自引率需警惕。总体而言，该期刊适合从事药物生物技术研究的学者投稿，但投稿前建议结合具体研究方向和中科院分区评价综合考量。

IF Trend

Recent Articles

Protein Phosphatase 2A Modulates AKT-Mediated Macrophage Polarization in Adipocyte-Induced Inflammation 2026-09-14

Celebrating 25 Years of Current Pharmaceutical Biotechnology 2026-09-11

Modeling M. tuberculosis Response to Antibiotics: A Comparison of Logarithmic, Logistic, and Michaelis-Menten Models 2026-09-05

A Study on the Mechanism of Action of Isorhamnetin in the Treatment of Depression using Network Pharmacology, Molecular Docking Technology and Experimental Validation 2026-08-31

Infosomes Define a New Paradigm in Inflammasome-Driven Intercellular Communication 2026-08-31

Uncovering Immunometabolic Mechanisms and Biomarkers in Diabetic Foot Ulcers: A Multi-omics Approach 2026-08-31

Recent Advances in the Development of Novel Strategies for LongCirculating Drug Formulation 2026-08-31

Eco-Friendly Silver Nanoparticles Synthesized from an Alkaloid-Rich Extract of Androcymbium palaestinum: Optimization, Characterization, and Activity Against Antibiotic-Resistant Bacteria 2026-08-27

Carnosol Attenuates Neointimal Hyperplasia in Spontaneously Hypertensive Rats: A Network Pharmacology, Molecular Docking, and Experimental Validation Study Targeting the PPAR-γ/AGTR1 Pathway 2026-08-24

Formulation and Characterization of Lipidic Vesicles Utilizing CCD for Enhanced Permeation of Phenylephrine HCl for Prevention of CIA 2026-08-21